NikolaiAlexandrovichPodoltsevMD

PubMed

• Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and Recruitment.
  Ayesha Butt, Jana Christian, Anna Kress, Benjamin Y Lu, Michael E Hurwitz, Sarah B Goldberg, Nikolai A Podoltsev, Luci Gilkes, Alfred Ian Lee> ;Journal of Cancer Education. 2024 Mar 2
• A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or ...
  Jan Philipp Bewersdorf, Rory M Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E Roe, Jonathan M Irish, Anne Caldwell, Wei Wei, Abdulraheem Yacoub, Yazan ...> ;Annals of Hematology. 2024 Jan 1
• 1 citations
  A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML.
  Guillermo Garcia-Manero, Nikolai A Podoltsev, Megan Othus, John M Pagel, Jerald P Radich, Min Fang, David A Rizzieri, Guido Marcucci, Stephen A Strickland, Mark R Litz...> ;Leukemia. 2024 Jan 1
• 2 citations
  Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia.
  Nikolai A Podoltsev, Rong Wang, Rory M Shallis, Jessica M Stempel, Mengyang Di, Natalia Neparidze, Amer M Zeidan, Scott F Huntington, Smith Giri, Sarah C Hull, Steven ...> ;Cancer Medicine. 2023 Sep 1
• 2 citations
  Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
  Keith W Pratz, Mohamad Cherry, Jessica K Altman, Brenda W Cooper, Nikolai A Podoltsev, Jose Carlos Cruz, Tara L Lin, Gary J Schiller, Joseph G Jurcic, Adam Asch, Ruish...> ;Journal of Clinical Oncology. 2023 Sep 10
• Supportive Care for Patients With Myelodysplastic Syndromes.
  Jessica M Stempel, Nikolai A Podoltsev, Talib Dosani> ;Cancer Journal. 2023 May 17
• Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome.
  Cecily Allen, Samir Gautam, Wei Cheng, Alexander B Pine, Nikolai A Podoltsev, Amer M Zeidan, Alfred I Lee, Rory M Shallis> ;Acta Haematologica. 2023 Jan 1
• 1 citations
  Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence.
  Rory M Shallis, Rong Wang, Amer M Zeidan, Scott F Huntington, Natalia Neparidze, Jessica M Stempel, Lourdes M Mendez, Mengyang Di, Xiaomei Ma, Nikolai A Podoltsev> ;Blood Advances. 2023 Jul 11
• 2 citations
  Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea.
  Rong Wang, Rory M Shallis, Jessica M Stempel, Scott F Huntington, Amer M Zeidan, Steven D Gore, Xiaomei Ma, Nikolai A Podoltsev> ;Blood Advances. 2023 Mar 14
• 1 citations
  Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with-mutant acute myeloid leukemia.
  Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory M Shallis, Nikolai A Podoltsev, Maximilian Stahl, Eytan M Stein, Scott F Huntington, Amer M Zeidan> ;Leukemia & Lymphoma. 2023 Feb 1
• 2 citations
  Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: a population-based analysis.
  Mengyang Di, Jessica B Long, Shalin K Kothari, Tarsheen Sethi, Amer M Zeidan, Nikolai A Podoltsev, Rory M Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington> ;Haematologica. 2023 Aug 1
• 9 citations
  Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versu...
  Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• Treatment of myelodysplasia-associated reactive, non-interstitial granulomatous dermatitis with hydroxychloroquine.
  Shaman Bhullar, Earl Glusac, Nikolai Podoltsev, Jonathan Leventhal, Choi, R.> ;International Journal of Dermatology. 2023 Jul 1
• Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm.
  Akash Gupta, Yuliya Afinogenova, Nikolai A Podoltsev, Abhijeet Danve> ;European Journal of Rheumatology. 2022 Oct 1
• 1 citations
  Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program Directors.
  Ayesha Butt, Michael Mankbadi, Clese Erikson, Ariela Marshall, Leah E Masselink, Guangyu Tong, Janet Hafler, Nikolai Podoltsev, Alfred Ian Lee> ;JCO Oncology Practice. 2022 Dec 1
• 29 citations
  Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  Aaron T Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar, Amro Elshoury, Tracy I George, Krishna Gundabolu, Elizabeth Hexner, Gabriela S Hobbs, Tania Jai...> ;Journal of the National Comprehensive Cancer Network. 2022 Sep 1
• 1 citations
  Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation.
  Jessica M Stempel, Nikolai A Podoltsev, Amer M Zeidan, Alfred I Lee, Rory M Shallis> ;Annals of Hematology. 2022 Nov 1
• Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database.
  Noa Rippel, Douglas Tremblay, Nicole Zubizarreta, Nikolai Podoltsev, Jason Gotlib, Mark Heaney, Andrew Kuykendall, Casey O'Connell, Jamile M Shammo, Angela Fleischman,...> ;Leukemia Research. 2022 Aug 1
• 4 citations
  Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period.
  Natalia Neparidze, Rong Wang, Amer M Zeidan, Nikolai A Podoltsev, Rory M Shallis, Xiaomei Ma, Amy J Davidoff, Scott F Huntington> ;Leukemia. 2022 Aug 1
• 6 citations
  Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis.
  Mengyang Di, Can Cui, Shalin K Kothari, Amer M Zeidan, Nikolai A Podoltsev, Natalia Neparidze, Rory M Shallis, Rong Wang, Xiaomei Ma, Scott F Huntington> ;Blood Advances. 2022 Jun 14
• 52 citations
  Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial.
  Alexander E Perl, Richard A Larson, Nikolai A Podoltsev, Stephen Strickland, Eunice S Wang, Ehab Atallah, Gary J Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge...> ;Blood. 2022 Jun 9
• 7 citations
  European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera.
  Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner, Nikolai Podoltsev, Jason Gotlib, Mark L Heaney, Andrew Kuykendall, Casey L O'Connell, Jamile M Shammo, Angela F...> ;Hemasphere. 2022 Jun 1
• 19 citations
  Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
  Alexander E Perl, Naoko Hosono, Pau Montesinos, Nikolai Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C Smith, Mark J Levis, Stephen ...> ;Blood Cancer Journal. 2022 May 30
• 5 citations
  Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia.
  Jan Philipp Bewersdorf, Kishan K Patel, George Goshua, Rory M Shallis, Nikolai A Podoltsev, Scott F Huntington, Amer M Zeidan> ;Blood. 2022 Mar 17
• 5 citations
  Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia in the United States.
  Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Rong Wang, Amer M. Zeidan, Amy J. Davidoff> ;Blood Advances. 2021 Nov 1
• Join now to see all

Abstracts/Posters

• Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neopl...
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Persistent Leukocytosis in Polycythemia Vera Is Associated with Disease Evolution but Not Thrombosis: An Analysis from a 520-Patient Retrospective Multi-Center Database
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Blinatumomab
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 1b Study of the Epichaperome Inhibitor PU-H71 Administered Orally with Ruxolitinib Continuation for the Treatment of Patients with Myelofibrosis
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The VITAL Trial: Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of acute Myeloid LeukemiaClinically Relevant Abstract
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Outcomes of Older Patients (pts) with Acute Myeloid Leukemia (AML) Receiving Hypomethylating Agents (HMAs): A Large Population-Based Study in the United State...
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab Ozogamicin
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Effectiveness of Hypomethylating Agents (HMAs) and Lenalidomide (Len) in Older Patients (pts) with Refractory Anemia with Ring Sideroblasts: A Large Populatio...
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Populati...
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best...
  Nikolai A. Podoltsev, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• The Impact of the 2011 European Leukemianet (ELN) Guidelines for Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms on Therapeutic Phlebotomy and ... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Impact of Leukapheresis and Time to Chemotherapy on Outcomes of Newly Diagnosed Patients (pts) with Acute Myeloid Leukemia (AML) Presenting with Hyperleukocytosis: An ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018